Related Experiment Video
Updated: Feb 15, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3
Youzhou Sang1, Yanxin Li2, Lina Song1
1State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
Aberrant EGFR signaling is a common driver of glioblastoma (GBM) pathogenesis; however, the downstream effectors that sustain this oncogenic pathway remain unclarified. Here we demonstrate that tripartite motif-containing protein 59 (TRIM59) acts as a new downstream effector of EGFR signaling by regulating STAT3 activation in GBM. EGFR signaling led to TRIM59 upregulation through SOX9 and enhanced the interaction between TRIM59 and nuclear STAT3, which prevents STAT3 dephosphorylation by the nuclear form of T-cell protein tyrosine phosphatase (TC45), thereby maintaining transcriptional activation and promoting tumorigenesis. Silencing TRIM59 suppresses cell proliferation, migration, and orthotopic xenograft brain tumor formation of GBM cells and glioma stem cells. Evaluation of GBM patient samples revealed an association between EGFR activation, TRIM59 expression, STAT3 phosphorylation, and poor prognoses. Our study identifies TRIM59 as a new regulator of oncogenic EGFR/STAT3 signaling and as a potential therapeutic target for GBM patients with EGFR activation.Significance: These findings identify a novel component of the EGFR/STAT3 signaling axis in the regulation of glioma tumorigenesis. Cancer Res; 78(7); 1792-804. ©2018 AACR.
Insights
Tripartite motif-containing protein 59 (TRIM59) is a novel downstream effector of epidermal growth factor receptor (EGFR) signaling in glioblastoma. Targeting TRIM59 may offer a new therapeutic strategy for glioblastoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Aberrant epidermal growth factor receptor (EGFR) signaling drives glioblastoma (GBM) pathogenesis.
- Downstream effectors sustaining EGFR oncogenic signaling in GBM are not fully understood.
Purpose of the Study:
- To identify novel downstream effectors of EGFR signaling in GBM.
- To investigate the role of tripartite motif-containing protein 59 (TRIM59) in GBM tumorigenesis.
Main Methods:
- Investigated TRIM59 as a downstream effector of EGFR signaling.
- Examined the regulation of STAT3 activation by TRIM59.
- Assessed the impact of TRIM59 silencing on GBM cell proliferation, migration, and tumor formation.
- Correlated EGFR activation, TRIM59 expression, and STAT3 phosphorylation with GBM patient prognoses.
Main Results:
- EGFR signaling upregulates TRIM59 via SOX9, enhancing TRIM59 interaction with nuclear STAT3.
- TRIM59 prevents STAT3 dephosphorylation by TC45, maintaining STAT3 transcriptional activity.
- TRIM59 silencing inhibits GBM cell proliferation, migration, and orthotopic xenograft formation.
- GBM patient samples show a link between EGFR activation, TRIM59 expression, STAT3 phosphorylation, and poor prognosis.
Conclusions:
- TRIM59 is a novel downstream effector of EGFR/STAT3 signaling in GBM.
- TRIM59 plays a critical role in GBM cell proliferation, migration, and tumorigenesis.
- TRIM59 represents a potential therapeutic target for EGFR-activated GBM.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Feedback Inhibition
Enzyme Inhibition
Anaphase Promoting Complex
Inhibition of Cdk Activity

